Drugs / RO5045377
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01635296 | Jul 2012 → Oct 2013 | acute myeloid leukemia | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO5045377 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01635296 ↗ |
| Route | Oral | “Multiple escalating oral doses, Days 1 to 10 of each 28-day cycle” NCT01635296 ↗ |